Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-001071
Filing Date
2018-01-16
Accepted
2018-01-16 16:05:35
Documents
2
Period of Report
2018-01-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4178
2 EX-24 DOCUMENT attachment1.htm EX-24 3748
  Complete submission text file 0000899243-18-001071.txt   9326
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Issuer) CIK: 0001496671 (see all company filings)

EIN.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address CALITHERA BIOSCIENCES 343 OYSTER POINT, SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address
Molineaux Christopher (Reporting) CIK: 0001618120 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36644 | Film No.: 18528654